精準醫療軟體市場規模、佔有率和成長分析（按交付方式、按應用、按最終用戶、按地區）：產業預測 (2024-2031)

2022年全球精準醫療軟體市場規模為13.1億美元，從2023年的14.8億美元成長到2031年的38.1億美元，預測期間（2024-2031年）預計複合年成長率為12.6%。

在技​​術進步和對個人化醫療解決方案日益成長的需求的推動下，全球精準醫療軟體市場正在迅速發展。該軟體使醫療保健提供者能夠分析大量患者資料並製定考慮遺傳、環境和生活方式變化的客製化治療計劃。市場擴張的主要促進因素包括慢性病盛行率的上升、基因組學和蛋白​​質組學的進步、電子健康記錄的日益普及以及政府的支持政策。此外，人工智慧和機器學習演算法的結合增強了精準醫療軟體的功能，並有望在不久的將來進一步推動市場成長。整體趨勢強調轉向客製化醫療方法，以最佳化患者的治療結果。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 專利分析
• 案例研究

全球精準醫療軟體市場規模及複合年成長率：以交付方式分類（2024-2031）

• 市場概況
• 雲端基礎
• 本地

全球精準醫療軟體市場規模及複合年成長率：依應用分類（2024-2031）

• 市場概況
• 腫瘤學
• 藥物基因體學
• 罕見疾病

全球精準醫療軟體市場規模與複合年成長率：依最終用戶分類（2024-2031）

• 市場概況
• 醫療提供者
• 研究中心/學術機構
• 製藥和生物技術公司

全球精準醫療軟體市場規模/複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• IBM Watson Health
• Oracle Corporation
• SAP SE
• SAS Institute Inc.
• Microsoft Corporation
• Flatiron Health, Inc.
• Syapse, Inc.
• Fabric Genomics, Inc.
• N-of-One, Inc.
• Gene42, Inc.
• PierianDx
• LifeOmic
• Tempus Labs, Inc.
• 2bPrecise LLC
• Human Longevity, Inc.
• GNS Healthcare
• Seven Bridges Genomics
• WuXi NextCODE
• Foundation Medicine, Inc.
• Strand Life Sciences

結論和建議

Global Precision Medicine Software Market size was valued at USD 1.31 billion in 2022 and is poised to grow from USD 1.48 billion in 2023 to USD 3.81 billion by 2031, growing at a CAGR of 12.6% during the forecast period (2024-2031).

The global precision medicine software market is rapidly evolving, fueled by technological advancements and a growing demand for personalized healthcare solutions. This software empowers healthcare providers to analyze extensive patient data, enabling customized treatment plans that account for genetic, environmental, and lifestyle variations. Key drivers of market expansion include the rising incidence of chronic diseases, advancements in genomics and proteomics, a growing adoption of electronic health records, and supportive government policies. Additionally, the incorporation of artificial intelligence and machine learning algorithms is poised to enhance the capabilities of precision medicine software, further propelling market growth in the near future. The overall trend underscores a transformative shift towards tailored healthcare approaches, optimizing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Medicine Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Medicine Software Market Segmental Analysis

Global Precision Medicine Software Market is segmented by delivery mode, application, end user and region. Based on delivery mode, the market is segmented into web & cloud-based and on-premises. Based on application, the market is segmented into oncology, pharmacogenomics and rare diseases. Based on end user, the market is segmented into healthcare providers, research centers and academic institutes and pharmaceutical and biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Precision Medicine Software Market

A significant driver of the global precision medicine software market is the rising demand for personalized healthcare solutions. As precision medicine focuses on delivering customized treatments tailored to an individual's unique genetic profile, lifestyle, and environmental influences, the need for corresponding software has surged. Technological advancements in genomic sequencing and big data analytics have made it easier to incorporate precision medicine into healthcare practices. This software allows providers to sift through extensive patient data, including genetic and medical histories, along with real-time monitoring, enabling more personalized treatment decisions. Growing awareness among patients and healthcare professionals about precision medicine's benefits continues to amplify the demand for supporting software solutions.

Restraints in the Global Precision Medicine Software Market

The global precision medicine software market faces significant restraints primarily due to the complexity and high costs involved in implementation and integration. This field necessitates the handling of vast amounts of genomic and clinical data, which requires sophisticated software systems capable of accurate analysis. However, healthcare organizations often encounter challenges, including interoperability issues and data privacy concerns, which complicate the integration process. Moreover, the extensive training required for healthcare professionals adds another layer of difficulty. High acquisition, maintenance, and upgrading costs further deter smaller healthcare institutions or those in resource-limited areas, hindering their capacity to adopt these advanced medical technologies.

Market Trends of the Global Precision Medicine Software Market

The global precision medicine software market is currently experiencing transformative trends that are reshaping healthcare delivery. A notable trend is the rising incorporation of artificial intelligence (AI) and machine learning (ML) technologies, which enhance diagnostic accuracy and facilitate the development of tailored treatment plans, ultimately leading to improved patient outcomes. Additionally, the increased embrace of cloud-based platforms is driving the secure, efficient storage and analysis of vast genomic and clinical datasets, further streamlining workflows. Moreover, a strong emphasis on interoperability and data standardization is fostering better integration among disparate healthcare systems, promoting collaboration among providers. Collectively, these trends are accelerating the adoption of precision medicine software, positioning it as a cornerstone of modern healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Precision Medicine Software Market Size by Delivery Mode & CAGR (2024-2031)

• Market Overview
• Web & Cloud-Based
• On-Premises

Global Precision Medicine Software Market Size by Application & CAGR (2024-2031)

• Market Overview
• Oncology
• Pharmacogenomics
• Rare Diseases

Global Precision Medicine Software Market Size by End User & CAGR (2024-2031)

• Market Overview
• Healthcare Providers
• Research Centers and Academic Institutes
• Pharmaceutical and Biotechnology Companies

Global Precision Medicine Software Market Size & CAGR (2024-2031)

• North America (Delivery Mode, Application, End User)
  • US
  • Canada
• Europe (Delivery Mode, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Delivery Mode, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Delivery Mode, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Delivery Mode, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAP SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS Institute Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syapse, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fabric Genomics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• N-of-One, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gene42, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PierianDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeOmic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus Labs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 2bPrecise LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Longevity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GNS Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seven Bridges Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi NextCODE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foundation Medicine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strand Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation